Literature DB >> 26568560

Predictors of outcome in HSV encephalitis.

Tarun D Singh1, Jennifer E Fugate1, Sara Hocker1, Eelco F M Wijdicks1, Allen J Aksamit1, Alejandro A Rabinstein2.   

Abstract

This study aims to explore the clinical features, radiological findings, management and the factors influencing prognosis in PCR-confirmed herpes simplex virus encephalitis (HSE). This is a retrospective review of consecutive patients diagnosed with HSE at Mayo Clinic, Rochester, MN, between January 1995 and December 2013. Only HSE cases confirmed by PCR were included. Univariate and multivariate analysis was used to identify factors associated with good (modified Rankin Scale of 0-2) or poor outcome (mRS of 3-6) at hospital discharge and 1-year follow-up. We identified 45 patients with HSE. Median age was 66 (IQR 53.5-78) years. HSE was caused by HSV-1 in 33 cases and by HSV-2 in 9. Nearly half had seizures upon admission or during hospitalization. The most common regions involved on MRI were the temporal lobe in 35 (87.5%), insula in 28 (70.0%), frontal lobe in 27 (67.5%) and thalamus in 11 (27.5%) patients. MRI pattern was quite homogeneous with HSV-1 infection, but much more heterogeneous with HSV-2. Good outcome at discharge and at 6-12 months was seen in 16 (35.6%) and 27 (65.9%) patients, respectively. On multivariate analyses, older age (p = 0.001), coma (p = 0.008), restricted diffusion on MRI (p = 0.005) and acyclovir started after the first day of admission (p = 0.050) were associated with poor outcome at discharge. Older age, development of coma, presence of restricted diffusion on brain MRI and delay in the administration of acyclovir portend poor outcome in HSE. Conversely, presence of seizures, focal neurological deficits, EEG abnormalities and location or extension of FLAIR/T2 abnormalities did not influence functional outcome.

Entities:  

Keywords:  DWI; Encephalitis; Herpes simplex virus; Imaging; Outcome; Viral infections

Mesh:

Year:  2015        PMID: 26568560     DOI: 10.1007/s00415-015-7960-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome.

Authors:  N McGrath; N E Anderson; M C Croxson; K F Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

2.  Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients.

Authors:  Uluhan Sili; Abdurrahman Kaya; Ali Mert
Journal:  J Clin Virol       Date:  2014-03-25       Impact factor: 3.168

3.  Diffusion-weighted MRI for early diagnosis of neonatal herpes simplex encephalitis.

Authors:  Tohru Okanishi; Hiroyuki Yamamoto; Takatoshi Hosokawa; Naoki Ando; Yoshihisa Nagayama; Yuji Hashimoto; Toshiro Maihara; Tomohide Goto; Tetsuo Kubota; Chiharu Kawaguchi; Hiroshi Yoshida; Katsumi Sugiura; Seiko Itomi; Koyo Ohno; Jun-ichi Takanashi; Masahiro Hayakawa; Hiroshi Otsubo; Akihisa Okumura
Journal:  Brain Dev       Date:  2014-08-20       Impact factor: 1.961

4.  Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid.

Authors:  E Aurelius; B Johansson; B Sköldenberg; A Staland; M Forsgren
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

5.  The spectrum of acute encephalitis: causes, management, and predictors of outcome.

Authors:  Tarun D Singh; Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

6.  Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile.

Authors:  N Kapur; S Barker; E H Burrows; D Ellison; J Brice; L S Illis; K Scholey; C Colbourn; B Wilson; M Loates
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

7.  Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

Authors:  B Sköldenberg; M Forsgren; K Alestig; T Bergström; L Burman; E Dahlqvist; A Forkman; A Frydén; K Lövgren; K Norlin
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

8.  Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis.

Authors:  J Poissy; M Wolff; A Dewilde; F Rozenberg; F Raschilas; M Blas; H Georges; C Chaffaut; Y Yazdanpanah
Journal:  Clin Microbiol Infect       Date:  2009-04-21       Impact factor: 8.067

9.  Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis.

Authors:  Vijay Sawlani
Journal:  J Neurol Sci       Date:  2009-09-03       Impact factor: 3.181

10.  Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy.

Authors:  John W Gnann; Birgit Sköldenberg; John Hart; Elisabeth Aurelius; Silvia Schliamser; Marie Studahl; Britt-Marie Eriksson; Daniel Hanley; Fred Aoki; Alan C Jackson; Paul Griffiths; Lil Miedzinski; Diane Hanfelt-Goade; Daniel Hinthorn; Clas Ahlm; Allen Aksamit; Salvador Cruz-Flores; Ilet Dale; Gretchen Cloud; Penelope Jester; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2015-05-08       Impact factor: 9.079

View more
  16 in total

Review 1.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

2.  Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study.

Authors:  P Jaquet; E de Montmollin; C Dupuis; C Sazio; M Conrad; V Susset; S Demeret; J M Tadie; L Argaud; F Barbier; B Sarton; R Chabane; D Daubin; N Brulé; N Lerolle; M Alves; D Da Silva; A El Kalioubi; S Silva; P Bailly; M Wolff; L Bouadma; J F Timsit; R Sonneville
Journal:  Intensive Care Med       Date:  2019-07-10       Impact factor: 17.440

3.  Role of 3D Pseudocontinuous Arterial Spin-Labeling Perfusion in the Diagnosis and Follow-Up in Patients with Herpes Simplex Encephalitis.

Authors:  R Li; P-A Shi; T-F Liu; Y Li; Y Wang; K Wu; X-J Chen; H-F Xiao; Y-L Wang; L Ma; X Lou
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

Review 4.  Herpes Simplex Encephalitis: an Update.

Authors:  John W Gnann; Richard J Whitley
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

5.  Long-Term Survival, Morbidity, Social Functioning and Risk of Disability in Patients with a Herpes Simplex Virus Type 1 or Type 2 Central Nervous System Infection, Denmark, 2000-2016.

Authors:  Ann-Brit E Hansen; Hanne T Vestergaard; Ram B Dessau; Jacob Bodilsen; Nanna S Andersen; Lars H Omland; Claus B Christiansen; Svend Ellermann-Eriksen; Lene Nielsen; Thomas Benfield; Henrik T Sørensen; Christian Ø Andersen; Anne-Mette Lebech; Niels Obel
Journal:  Clin Epidemiol       Date:  2020-07-16       Impact factor: 4.790

6.  Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes.

Authors:  Bryan H Lin; Michael R Sutherland; Federico I Rosell; James H Morrissey; Edward L G Pryzdial
Journal:  J Thromb Haemost       Date:  2020-04-09       Impact factor: 5.824

7.  Characteristics and outcome of varicella-zoster virus central nervous system infections in adults.

Authors:  A Le Bot; A Ballerie; C Pronier; F Bénézit; F Reizine; M Tas; P Jégo; M Revest; Y Le Tulzo; P Fillâtre; Pierre Tattevin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-28       Impact factor: 3.267

8.  A study on viral CNS inflammation beyond herpes encephalitis.

Authors:  Berit Jordan; Sabrina Kösling; Alexander Emmer; Antje Koch; Tobias Müller; Malte Kornhuber
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 3.739

9.  Predictors of Outcome in Clinically Diagnosed Viral Encephalitis Patients: A 5-Year Prospective Study.

Authors:  Guibo Feng; Lunqin Zhou; Feng Li; Yida Hu; Xuefeng Wang; Xin Tian
Journal:  Biomed Res Int       Date:  2020-07-08       Impact factor: 3.411

10.  Increased level of compleasomes in cerebrospinal fluid of patients with herpes simplex encephalitis.

Authors:  Ewa Johansson; Stefan Lange; Tomas Bergström; Merna Oshalim; Ivar Lönnroth; Marie Studahl
Journal:  J Neurovirol       Date:  2018-08-09       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.